Current Neurovascular Research
Title: Erratum
Volume: 2 Issue: 2
Export Options
About this article
Cite this article as:
Erratum, Current Neurovascular Research 2005; 2 (2) . https://dx.doi.org/10.2174/1567202053586857
DOI https://dx.doi.org/10.2174/1567202053586857 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
RNAi Applications in Therapy Development for Neurodegenerative Disease
Current Pharmaceutical Design Effect of Ionic Strength on the Aggregation Propensity of Aβ<sub>1-42</sub> Peptide: An In-silico Study
Current Chemical Biology Depression and Treatment with Effective Herbs
Current Pharmaceutical Design Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis
Current Neuropharmacology Anticancer Agents: Towards the Future
Current Medicinal Chemistry - Anti-Cancer Agents Medico-Legal Issues with CTG Interpretation
Current Women`s Health Reviews Peak Treadmill Exercise Echocardiography
Reviews on Recent Clinical Trials Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Acknowledgements to Reviewers
Current Medicinal Chemistry Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium
Current Diabetes Reviews Aluminum Excytotoxicity and NeuroAutotoImmunity: The Role of the Brain Expression of CD32+ (FcγRIIa), ICAM-1+ and CD3ع in Aging
Current Aging Science Mycoinsecticides: Potential and Future Perspective
Recent Patents on Food, Nutrition & Agriculture Alzheimers Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies
Current Drug Targets - CNS & Neurological Disorders The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine
Current Medicinal Chemistry Antibiotic Properties and Applications of Lactoferrin
Current Pharmaceutical Design Editorial (Hot Topic: The Potential of Psychedelics as a Preventative and Auxiliary Therapy for Drug Abuse)
Current Drug Abuse Reviews Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Preface
Current Psychopharmacology The Efficacy of Psychological Therapies for Specific Phobias in Adults and Some Unanswered Questions
Current Psychiatry Reviews